| Type I diabetes mellitus |
-1.68 |
3.78e-2 |
38/43 (88.37%) |
HLA-DQA1;HLA-DQB1;HLA-DRB1;...
|
| AMPK signaling pathway |
-1.74 |
2.07e-2 |
106/120 (88.33%) |
IRS2;RAB8A;PPP2R2A;...
|
| Systemic lupus erythematosus |
-1.75 |
2.01e-2 |
45/135 (33.33%) |
SSB;HLA-DQA1;HLA-DQB1;...
|
| Legionellosis |
-1.76 |
1.81e-2 |
51/57 (89.47%) |
NFKB1;RAB1A;CASP8;...
|
| PPAR signaling pathway |
-1.76 |
1.95e-2 |
66/74 (89.19%) |
ACOX3;MMP1;ANGPTL4;...
|
| Rheumatoid arthritis |
-1.80 |
1.46e-2 |
78/93 (83.87%) |
IFNG;ATP6V1B2;TNFSF11;...
|
| Pertussis |
-1.81 |
1.59e-2 |
64/76 (84.21%) |
CALML3;PYCARD;MAPK13;...
|
| Asthma |
-1.82 |
1.65e-2 |
25/31 (80.65%) |
IL10;RNASE3;MS4A2;...
|
| Fatty acid biosynthesis |
-1.83 |
1.51e-2 |
16/18 (88.89%) |
ACSL4;ACSBG1;ACACA;...
|
| Allograft rejection |
-1.85 |
1.09e-2 |
32/38 (84.21%) |
HLA-DQA1;HLA-DQB1;HLA-DRB1;...
|
| Graft-versus-host disease |
-1.92 |
1.39e-3 |
32/42 (76.19%) |
HLA-E;KIR3DL1;IL1B;...
|
| Viral myocarditis |
-1.94 |
1.62e-3 |
53/60 (88.33%) |
HLA-DQA1;HLA-DQB1;ABL1;...
|
| Intestinal immune network for IgA production |
-1.94 |
1.95e-3 |
38/48 (79.17%) |
HLA-DQA1;HLA-DQB1;ICOS;...
|
| Complement and coagulation cascades |
-2.01 |
0.00e+0 |
76/85 (89.41%) |
C3AR1;F13A1;C5AR1;...
|
| Staphylococcus aureus infection |
-2.05 |
0.00e+0 |
72/95 (75.79%) |
HLA-DPA1;DEFA5;HLA-DPB1;...
|
| Cytokine-cytokine receptor interaction |
-2.21 |
0.00e+0 |
246/295 (83.39%) |
IL3RA;IL4;TNFRSF10B;...
|
| Viral protein interaction with cytokine and cytokine re... |
-2.28 |
0.00e+0 |
84/100 (84%) |
TNFRSF10B;CCR9;IL24;...
|
